Raboisson P - Search Results

1

Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates.

Goethals O, Kaptein SJF, Kesteleyn B, Bonfanti JF, Van Wesenbeeck L, Bardiot D, Verschoor EJ, Verstrepen BE, Fagrouch Z, Putnak JR, Kiemel D, Ackaert O, Straetemans R, Lachau-Durand S, Geluykens P, Crabbe M, Thys K, Stoops B, Lenz O, Tambuyzer L, De Meyer S, Dallmeier K, McCracken MK, Gromowski GD, Rutvisuttinunt W, Jarman RG, Karasavvas N, Touret F, Querat G, de Lamballerie X, Chatel-Chaix L, Milligan GN, Beasley DWC, Bourne N, Barrett ADT, Marchand A, Jonckers THM, Raboisson P, Simmen K, Chaltin P, Bartenschlager R, Bogers WM, Neyts J, Van Loock M. Goethals O, et al. Among authors: raboisson p. Nature. 2023 Mar;615(7953):678-686. doi: 10.1038/s41586-023-05790-6. Epub 2023 Mar 15. Nature. 2023. PMID: 36922586 Free PMC article.

2

Design, synthesis and structure-activity relationships of a series of 9-substituted adenine derivatives as selective phosphodiesterase type-4 inhibitors.

Raboisson P, Lugnier C, Muller C, Reimund JM, Schultz D, Pinna G, Le Bec A, Basaran H, Desaubry L, Gaudiot F, Seloum M, Bourguignon JJ. Raboisson P, et al. Eur J Med Chem. 2003 Feb;38(2):199-214. doi: 10.1016/s0223-5234(02)01446-0. Eur J Med Chem. 2003. PMID: 12620664

3

Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein-protein interaction through structure-based drug design.

Parks DJ, LaFrance LV, Calvo RR, Milkiewicz KL, Marugán JJ, Raboisson P, Schubert C, Koblish HK, Zhao S, Franks CF, Lattanze J, Carver TE, Cummings MD, Maguire D, Grasberger BL, Maroney AC, Lu T. Parks DJ, et al. Among authors: raboisson p. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3310-4. doi: 10.1016/j.bmcl.2006.03.055. Epub 2006 Apr 4. Bioorg Med Chem Lett. 2006. PMID: 16600594

4

Novel potent and selective alphavbeta3/alphavbeta5 integrin dual antagonists with reduced binding affinity for human serum albumin.

Raboisson P, Manthey CL, Chaikin M, Lattanze J, Crysler C, Leonard K, Pan W, Tomczuk BE, Marugán JJ. Raboisson P, et al. Eur J Med Chem. 2006 Jul;41(7):847-61. doi: 10.1016/j.ejmech.2006.03.008. Epub 2006 May 11. Eur J Med Chem. 2006. PMID: 16697080

5

Synthesis and SAR of potent inhibitors of the Hepatitis C virus NS3/4A protease: exploration of P2 quinazoline substituents.

Nilsson M, Belfrage AK, Lindström S, Wähling H, Lindquist C, Ayesa S, Kahnberg P, Pelcman M, Benkestock K, Agback T, Vrang L, Terelius Y, Wikström K, Hamelink E, Rydergård C, Edlund M, Eneroth A, Raboisson P, Lin TI, de Kock H, Wigerinck P, Simmen K, Samuelsson B, Rosenquist S. Nilsson M, et al. Among authors: raboisson p. Bioorg Med Chem Lett. 2010 Jul 15;20(14):4004-11. doi: 10.1016/j.bmcl.2010.05.029. Epub 2010 May 21. Bioorg Med Chem Lett. 2010. PMID: 20541405

6

A general approach toward the synthesis of C-nucleoside pyrazolo[1,5-a]-1,3,5-triazines and their 3',5'-bisphosphate C-nucleotide analogues as the first reported in vivo stable P2Y(1)-receptor antagonists.

Raboisson P, Baurand A, Cazenave JP, Gachet C, Schultz D, Spiess B, Bourguignon JJ. Raboisson P, et al. J Org Chem. 2002 Nov 15;67(23):8063-71. doi: 10.1021/jo026268l. J Org Chem. 2002. PMID: 12423133

7

Novel antagonists acting at the P2Y(1) purinergic receptor: synthesis and conformational analysis using potentiometric and nuclear magnetic resonance titration techniques.

Raboisson P, Baurand A, Cazenave JP, Gachet C, Retat M, Spiess B, Bourguignon JJ. Raboisson P, et al. J Med Chem. 2002 Feb 14;45(4):962-72. doi: 10.1021/jm0104062. J Med Chem. 2002. PMID: 11831909

8

Binding-site identification and genotypic profiling of hepatitis C virus polymerase inhibitors.

Pauwels F, Mostmans W, Quirynen LM, van der Helm L, Boutton CW, Rueff AS, Cleiren E, Raboisson P, Surleraux D, Nyanguile O, Simmen KA. Pauwels F, et al. Among authors: raboisson p. J Virol. 2007 Jul;81(13):6909-19. doi: 10.1128/JVI.01543-06. Epub 2007 Apr 25. J Virol. 2007. PMID: 17459932 Free PMC article.

9

Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist.

Baurand A, Raboisson P, Freund M, Léon C, Cazenave JP, Bourguignon JJ, Gachet C. Baurand A, et al. Among authors: raboisson p. Eur J Pharmacol. 2001 Feb 2;412(3):213-21. doi: 10.1016/s0014-2999(01)00733-6. Eur J Pharmacol. 2001. PMID: 11166284

10

Monoaryl- and bisaryldihydroxytropolones as potent inhibitors of inositol monophosphatase.

Piettre SR, André C, Chanal MC, Ducep JB, Lesur B, Piriou F, Raboisson P, Rondeau JM, Schelcher C, Zimmermann P, Ganzhorn AJ. Piettre SR, et al. Among authors: raboisson p. J Med Chem. 1997 Dec 19;40(26):4208-21. doi: 10.1021/jm9701942. J Med Chem. 1997. PMID: 9435892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page